SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for BANK OF AMERICA (BAC) — Jul 2, 2014

BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BAC-PQ, BAC-PS, BML-PG, BML-PL) (CIK 0000070858)
Date: July 2, 2014 · CIK: 0000070858 · Accession: 0000000000-14-033535

Internal Controls Financial Reporting Regulatory Compliance

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-06523

Date
July 2, 2014
Author
/s/ Stephanie J. Ciboroski
Form
UPLOAD
Company
BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BAC-PQ, BAC-PS, BML-PG, BML-PL) (CIK 0000070858)

Letter

July 2, 2014 Via E -mail Bruce R. Thompson Chief Financial Officer Bank of America Corporation 100 North Tryon Street Charlotte, North Carolina 28255

Re: Bank of America Corporation Form 10 -K for the Fiscal Year Ended December 31, 2013 Filed February 25, 2014 Form 10 -Q for the Quarterly Period Ended March 31, 2014 Filed May 1, 2014 File No. 001-06523

Dear Thompson :

We have reviewed your filings and have the following comment . In our comment , we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this letter within ten business days by providing the requested information or by advising us when you will provide the requested response . If you do not believe our comment applies to your fact s and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your filing s and the information you provide in response to this comment , we may have additional comments. Form 10 -Q for the Quarterly Period Ended March 31, 2014 Executive Summary, page 4 Capital Management, page 5 1. We note your discl osure that you applied an incorrect adjustment in the determination of regulatory capital related to the treatment of the fair value option adjustment for structured notes assumed in the Merrill Lynch & Co. Inc. acquisition in 2009, resulting in an oversta tement of your historical regulatory capital ratios included in prior SEC filings and other regulatory reports. Additionally, on May 27, 2014, you filed an 8 -K disclosing that a third party was engaged to perform certain procedures related to your 2014 CC AR resubmission process and controls regarding reporting and calculation of regulatory capital ratios, focusing on the periods ended September 30, 2013 and March 31, 2014,

Bruce R. Thompson Bank of America Corporation July 2, 2014 Page 2

and that this review resulted in adjustments to your regulatory capital ratios for the period ended September 30, 2013. Lastly, we note that on June 2, 2014, a spokesman for the company noted that you made an error in calculating the volume data you sent to FINRA regarding the equity volume transacted on your alternative trading system. In light of these errors noted in your SEC and other regulatory reporting, please provide us with the following additional information:  Tell us whether the identification of the regulatory capital ratio error and subsequent adjustments are indicative of the existence of one or more material weaknesses in internal control over financial reporting (ICFR), and, if so, whether any such material weaknesses also would have existed as of December 31, 2013;

 To the extent you identified significant deficiencies in your original assessment of ICFR as of December 31, 2013, tell us the nature of each, including the impacted component(s) of the Committee of Sponsoring Organizations of the Treadway Commission (COSO) Internal Control Integrated Framework, and how you e valuated their severity individually and in the aggregate, including in aggregation with any deficiencies identified upon discovery of the above regulatory capital ratio errors, if applicable; and

 Upon discovery of the error related to alternative tradin g system volume in your regulatory reporting to FINRA, tell us the extent to which there may be common root causes to the errors in your regulatory capital ratio reporting that are relevant to the evaluation of the nature and severity of any deficiencies i n ICFR (especially the control environment, risk assessment, or monitoring components of COSO). We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includ es the information the Securities Exchange Act of 1934 and all applicable Exchange Act rules require. Since the company and its management are in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy and adequac y of the disclosures they have made.

In responding to our comments, please provide a written statement from the company acknowledging that:

 the company is responsible for the adequacy and accuracy of the disclosure in the filing;

 staff comments or ch anges to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and

 the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person und er the federal securities laws of the United States.

Bruce R. Thompson Bank of America Corporation July 2, 2014 Page 3

You may contact Lory Empie at (202) 551 -3714 or me at (202) 551 -3512 if you have any questions .

Sincerely,
/s/ Stephanie J. Ciboroski

Show Raw Text
July 2, 2014

Via E -mail
Bruce R. Thompson
Chief Financial Officer
Bank of America Corporation
100 North Tryon Street
Charlotte, North Carolina 28255

Re: Bank of America Corporation
Form 10 -K for the Fiscal Year Ended December 31, 2013
Filed February 25, 2014
Form 10 -Q for the Quarterly Period Ended March 31, 2014
Filed May 1, 2014
  File No. 001-06523

Dear Thompson :

We have reviewed your filings and  have the following comment .  In our comment , we
may ask you to provide us with information so we may better understand your disclosure.

Please respond to this letter  within ten business days  by providing the requested
information  or by advising us when you will provide the requested response .  If you do not
believe our comment  applies  to your fact s and circumstances or do not believe an amendment is
appropriate, please tell us why in your response.

After reviewing any amendment to your filing s and the information you provide in
response to this comment , we may have  additional comments.
Form 10 -Q for the Quarterly Period Ended March 31, 2014
Executive Summary, page 4
Capital Management, page 5
1. We note your discl osure that you applied an incorrect adjustment in the determination of
regulatory capital related to the treatment of the fair value option adjustment for
structured notes assumed in the Merrill Lynch & Co. Inc. acquisition in 2009, resulting in
an oversta tement of your historical regulatory capital ratios included in prior SEC filings
and other regulatory reports.   Additionally, on May 27, 2014, you filed an 8 -K disclosing
that a third party was engaged to perform certain procedures related to your 2014 CC AR
resubmission process and controls regarding reporting and calculation of regulatory
capital ratios, focusing on the periods ended   September 30, 2013 and March 31, 2014,

Bruce R. Thompson
Bank of America Corporation
July 2, 2014
Page 2

 and that this review resulted in adjustments to your regulatory capital ratios for the period
ended September 30, 2013.   Lastly, we note that on June 2, 2014, a spokesman for the
company noted that you made an error in calculating the volume data you sent to FINRA
regarding the equity volume transacted on your alternative trading system.   In light of
these errors noted in your SEC and other regulatory reporting, please provide us with the
following additional information:
 Tell us whether the identification of the regulatory capital ratio error and subsequent
adjustments are indicative of the existence of one or more material weaknesses in
internal control over financial reporting (ICFR), and, if so, whether any such material
weaknesses also would have existed as of December 31, 2013;

 To the extent you identified significant deficiencies in your original assessment of
ICFR as of December 31, 2013, tell us the nature of each, including the impacted
component(s) of the Committee of Sponsoring Organizations of the Treadway
Commission (COSO) Internal Control Integrated Framework, and how you e valuated
their severity individually and in the aggregate, including in aggregation with any
deficiencies identified upon discovery of the above regulatory capital ratio errors, if
applicable; and

 Upon discovery of the error related to alternative tradin g system volume in your
regulatory reporting to FINRA, tell us the extent to which there may be common root
causes to the errors in your regulatory capital ratio reporting that are relevant to the
evaluation of the nature and severity of any deficiencies i n ICFR (especially the
control environment, risk assessment, or monitoring components of COSO).
We urge all persons who are responsible for the accuracy and adequacy of the disclosure
in the filing to be certain that the filing includ es the information the Securities Exchange Act of
1934 and all applicable Exchange Act rules require.   Since the company and its management are
in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy
and adequac y of the disclosures they have made.

 In responding to our comments, please provide  a written statement from the company
acknowledging that:

 the company is responsible for the adequacy and accuracy of the disclosure in the filing;

 staff comments or ch anges to disclosure in response to staff comments do not foreclose
the Commission from taking any action with respect to the filing; and

 the company may not assert staff comments as a defense in any proceeding initiated by
the Commission or any person und er the federal securities laws of the United States.

Bruce R. Thompson
Bank of America Corporation
July 2, 2014
Page 3

 You may contact Lory Empie at (202) 551 -3714 or me at (202) 551 -3512 if you have  any
questions .

Sincerely,

 /s/ Stephanie J. Ciboroski

Senior Assistant Chief Accountant